Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Actuate Therapeutics, Inc. - Common stock (NQ:ACTU)

6.780 -0.490 (-6.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 65,300
Open 7.170
Bid (Size) 6.300 (1)
Ask (Size) 8.200 (11)
Prev. Close 7.270
Today's Range 6.710 - 7.205
52wk Range 5.470 - 11.99
Shares Outstanding 20,745,187
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer
Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026. 
Via Stocktwits
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga

Performance

YTD
-14.8%
-14.8%
1 Month
+0.1%
+0.1%
3 Month
+0.1%
+0.1%
6 Month
-26.0%
-26.0%
1 Year
-26.5%
-26.5%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
Via Benzinga
Actuate Therapeutics Advances a New Era in Oncology with Potential Universal Backbone Therapy
Via ACCESS Newswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Pheton, Powell Max Make Public Debut
Via Talk Markets
Actuate Therapeutics Makes Public Debut
Via Talk Markets
InvestorNewsBreaks – Actuate Therapeutics, Inc. (NASDAQ: ACTU) Closes on $22.4M Initial Public Offering
Via Investor Brand Network

Frequently Asked Questions

Is Actuate Therapeutics, Inc. - Common stock publicly traded?
Yes, Actuate Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Actuate Therapeutics, Inc. - Common stock trade on?
Actuate Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Actuate Therapeutics, Inc. - Common stock?
The ticker symbol for Actuate Therapeutics, Inc. - Common stock is ACTU on the Nasdaq Stock Market
What is the current price of Actuate Therapeutics, Inc. - Common stock?
The current price of Actuate Therapeutics, Inc. - Common stock is 6.780
When was Actuate Therapeutics, Inc. - Common stock last traded?
The last trade of Actuate Therapeutics, Inc. - Common stock was at 10/28/25 04:00 PM ET
What is the market capitalization of Actuate Therapeutics, Inc. - Common stock?
The market capitalization of Actuate Therapeutics, Inc. - Common stock is 140.65M
How many shares of Actuate Therapeutics, Inc. - Common stock are outstanding?
Actuate Therapeutics, Inc. - Common stock has 141M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.